Skip to main content Skip to main navigation menu Skip to site footer
MedNext Journal of Medical and Health Sciences
Review
DOI: 10.34256/mdnt2011
Submitted: 15-09-2021
Published: 04-11-2020

COVID-19. Who can help us?

Retired Professor, USA
COVID-19 Lung tissue Pneumonia Patients

Abstract

COVID-19 coronavirus infection, despite its high contagiousness and rapid spread, is not accompanied by the development of the disease in most infected people. The main cause of clinical manifestations of this infection is inflammation of the lung tissue, which affects the same parts of the organ as bacterial forms of pneumonia, accompanied by identical functional disorders. Functional disorders are caused by inflammatory transformation of tissues, not by the pathogen itself, and are manifested not so much in lung ventilation as in the effect through the pulmonary vessels on the blood circulation of the entire body. Most patients actually cope with the disease on their own, as there are no effective treatment methods yet. However, when the disease has a rapid and progressive course, pathogenetic methods are needed to really help patients, which can help the body adapt and avoid critical situations.

Metrics

Metrics Loading ...

References

  1. Zhe Xu, Lei Shi, Yijin Wang et al., Pathological findings of COVID-19 associated with acute respiratory distress syndrome, The Lancet Respiratory Medicine, 8 (2020) P420-422.
  2. M. Ackermann, S. E. Verleden, M. Kuehnel et al., Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. New England Journal of Medicine, 383 (2020) 120-128
  3. R. Feigin (2004) Textbook of Pediatric Infectious Diseases (5th ed.). Philadelphia: W. B. Saunders. p. 299.
  4. M. Lipman, R.C. Chambers, M. Singer, et al., SARS-CoV-2 pandemic: clinical picture of COVID-19 and implications for research. Thorax, 75 (2020) 614-616.
  5. J.P. Metlay, G.W. Waterer, A.C. Long at al.; Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America, American Journal of Respiratory and Critical Care Medicine, 200, (2019) e45-e67
  6. Paula Peyrani, Lionel Mandell, Antoni Torres & Glenn S Tillotson, The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance, Expert Review of Respiratory Medicine, 13 (2019) 139-152
  7. https://en.wikipedia.org/wiki/Severe_acute_respiratory_syndrome
  8. T.M. Rawson, L.S.P. Moore, N. Zhu, et al., Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing [published online ahead of print, Clinical Infectious Diseases, (2020) ciaa530.
  9. Beović, M. Doušak, J. Ferreira-Coimbra et al. Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey, Journal of Antimicrobial Chemotherapy, 75 (2020) 3386–3390
  10. D. Kim, J. Quinn, B. Pinsky et al. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens, JAMA 323 (2020) 2085–2086.
  11. Renato Seligman and Beatriz Graeff Santos Seligman, Pandemic in the 21st Century. The Challenge of COVID-19, EC Pulmonology and Respiratory Medicine 9 (2020) 30-31.
  12. David Koeckerling, Joseph Barker, Nadeesha L Mudalige, Oluwatobiloba Oyefeso, Daniel Pan, Manish Pareek, Jonathan P Thompson, G. Andre Ng, Awake prone positioning in COVID-19, Thorax, 75 (2020) 833-834.
  13. A.E. Thompson, B.L. Ranard, Y. Wei, Prone positioning in awake, nonintubated patients with COVID-19 hypoxemic respiratory failure, JAMA International Medicine, 180 (2020) 1537-1539.
  14. Stuart Winearls, Ema L Swingwood, Charlotte L Hardaker, Amy M Smith, Fraser M Easton, Katherine J Millington, Rebecca S Hall, Ann Smith and Katrina J Curtis, Early conscious prone positioning in patients with COVID-19 receiving continuous positive airway pressure: a retrospective analysis, BMJ, Open Respiratory Research, 7 (2020) e000711.
  15. Andrea Vianello, Giovanna Arcaro, Beatrice Molena, Cristian Turato, Andi Sukthi, Gabriella Guarnieri, Francesca Lugato, Gianenrico Senna, Paolo Navalesi, High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection, Thorax, 75 (2020) 998-1000.
  16. D. A. Berlin, R. M. Gulick, F. J. Martinez, Severe Covid-19, New England Journal of Medicine, (2020).
  17. M. L. Ranney, V. Griffeth, A.K. Jha (2020). Critical Supply Shortages — The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic, New England Journal of Medicine, 382 (2020) e41.
  18. A.J. Keeley, C.M. Evans, T.I. de Silva, Asymptomatic SARS-CoV-2 infection: the tip or the iceberg?, Thorax, 75 (2020) 621-622.
  19. A.J. Ing, C. Cocks, J.P. Green, COVID-19: in the footsteps of Ernest Shackleton, Thorax, 75 (2020) 693-694.
  20. I. Rudan, C. Boschi-Pinto, Z. Biloglav, K. Mulholland, H. Campbell, Epidemiology and etiology of childhood pneumonia, Bulletin of the World Health Organization, 86 (2008) 408–416.
  21. WHO Revised global burden of disease 2002 estimates. 2004.
  22. http://www.who.int/healthinfo/global_burden_disease/estimates_regional_2002_revised/en/ (Accessed Nov 5, 2010).
  23. Grasselli G et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy, JAMA 323 (2020) 1574-1581.
  24. S. Richardson, J. S. Hirsch, M. Narasimhan at al., Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area, JAMA, 323 (2020) 2052-2059.
  25. Weiss SL, Fitzgerald JC, Pappachan J, et al., Global epidemiology of pediatric severe sepsis: The sepsis prevalence, outcomes, and therapies study, American Journal of Respiratory and Critical Care Medicine, 191 (2015) 1147–1157
  26. A.J. Morgan, A.J. Glossop, Severe community-acquired pneumonia, BJA Education, 16 (2016) 167-172, DOI
  27. C. Garcia-Vidal, C. Ardanuy, F. Tubau, D. Viasus, J. Dorca, J. Liñares, F. Gudiol, J. Carratalà, Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes, Thorax, 65 (2010) 77-81.
  28. Alhazzani, W., Møller, M.H., Arabi, Y.M. et al., Surviving sepsis campaign: Guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19), Intensive Care Medicine, 46, (2020) 854–887.
  29. Igor Klepikov (2020) Acute pneumonia. New doctrine and first treatment results, LAP-Lambert Academic Publishing, Saarbrücken, Germany
  30. Editorial from The New England Journal of Medicine, Dying in a Leadership Vacuum, New England Journal of Medicine, 383 (2020) 1479-1480.

How to Cite

Klepikov, I. (2020). COVID-19. Who can help us?. MedNEXT Journal of Medical and Health Sciences, 1(1), 1–7. https://doi.org/10.34256/mdnt2011